Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05033756 |
Title | Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO) |
Acronym | COMPRENDO |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Institut fuer Frauengesundheit |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | DEU |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Department of Gynecology, Tübingen University Hospital | NOT_YET_RECRUITING | Tübingen | Baden-Württemberg | 72076 | Germany | Details |
University Hospital Ulm | NOT_YET_RECRUITING | Ulm | Baden-Württemberg | 89075 | Germany | Details |
Department of Gynecology and Obstetrics, Erlangen University Hospital | RECRUITING | Erlangen | Bavaria | 91054 | Germany | Details |
Marienhospital Bottrop | NOT_YET_RECRUITING | Bottrop | North Rhine Westphalia | 46236 | Germany | Details |
University Hospital Düsseldorf | NOT_YET_RECRUITING | Düsseldorf | North Rhine Westphalia | 40225 | Germany | Details |
Helios-Klinikum Berlin-Buch | RECRUITING | Berlin | 13125 | Germany | Details |